Meta Health eyes 30% of Aios Bio Sciences share capital

It is part of Meta Health’s efforts to grow the group’s healthcare business

Meta Health Limited is eyeing to acquire 30% of the entire issued and paid-up share capital of Aios Bio Sciences from Davin Ng and other shareholders. 

The transaction is part of Meta Health’s efforts to grow the group’s healthcare business and diversify its revenue streams by expanding into the complementary segment of the manufacturing and distribution of medical and surgical consumables.

Aios Bios is a private company limited by shares incorporated in Singapore on 25 July 2022.

Based on the information extracted from the Accounting and Corporate Regulatory Authority, Ng is a director of the company and holds 33.3% of the entire issued and paid share capital.